SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
The company regained compliance with Nasdaq's bid price rule after completing a mandatory one-for-six reverse stock split. This reinstatement is subje...
Microbot Medical entered a strategic agreement with Sanmina to manufacture the LIBERTY System to meet global demand. This partnership aims to lower co...
Moleculin reported positive interim results from its MIRACLE trial, showing Annamycin achieved three-fold higher complete remission rates than the con...
Moleculin Biotech has filed an exhibit with the SEC, usually containing supplementary information such as a press release. Investors should review thi...
Vistagen Therapeutics notified investors that its intranasal social anxiety drug failed to meet primary and secondary endpoints in the PALISADE-4 tria...
Former CEO Gregory Haskell agreed to provide transition services through April 30, 2027, in exchange for continued equity vesting and COBRA health cov...
Nauticus Robotics entered an exchange agreement to swap existing secured term loans for Series C preferred stock. This debt-for-equity transaction aim...
Sharplink acquired 10,000 ETH and repurchased 2.13 million shares while raising $75 million in a registered direct offering. This execution reinforces...
The company entered an underwriting agreement with Cantor Fitzgerald to sell 25 million units at $10.00 per unit. This capital raise is essential for ...
LCI Industries and Patrick Industries entered into a definitive merger agreement. This transaction outlines the structure and timeline for the combina...
Air Products will exit the LCEC project, incurring a $2.9 billion pre-tax charge driven by economic conditions and slower market development. The comp...
LQR House inked a two-year agreement with BytePlus to deploy advanced AI computing power. This strategic investment aims to enhance quantitative resea...
USRC and Akebia halted the VOICE trial due to improved safety outcomes with Vafseo compared to ESAs. The interim data indicates a significant reductio...
QXO has accepted for purchase nearly $1.25 billion of TopBuild Corp.'s senior notes, representing over 99% of the outstanding principal. This successf...
Vivani Medical Inc. filed an amended and restated 2022 omnibus incentive plan to authorize grants of stock awards to officers and directors. This gove...
Blue Acquisition Corp amended its business combination agreement with Blockfusion USA to add earnout provisions and reduce the post-merger board count...
Stoke Therapeutics reported completing enrollment for the zorevunersen Phase 3 EMPEROR study involving 162 patients. The biotech firm plans a U.S. NDA...
Monopar Therapeutics received Rare Pediatric Disease designation for ALXN1840 treating Wilson disease. This grants potential eligibility for a Pediatr...
Joby Aviation and Toyota Aero Manufacturing entered into a Stockholders Agreement dated June 29, 2026, defining key governance parameters. This move r...
Atlantic Union Bankshares Corp announced it will release second quarter 2026 results on July 21. The company will host a webcast at 9:00 a.m. ET to di...